Myalgic encephalomyelitis/chronic fatigue syndrome associated with mRNA COVID-19 vaccination

WorkSafeBC Evidence-Based Practice Group, Martin CW
Record ID 32018005428
English
Authors' objectives: To determine whether there is any evidence for the development of myalgic encephalomyelitis post-mRNA COVID-19 vaccination, particularly post-Moderna mRNA vaccination.
Authors' results and conclusions: Twenty-seven published studies were identified from the above search. Upon examination on the titles and abstracts of these twenty-seven studies, three studies were thought to be relevant and were retrieved in full for further appraisal. No further study was identified from manual searches. No data supporting the development of myalgic encephalomyelitis or chronic fatigue syndrome post mRNA covid-19 vaccination were reported by any of the three studies that were retrieved in full. At present, there is no published data to support the development of myalgic encephalomyelitis or chronic fatigue syndrome post mRNA COVID-19 vaccination.
Authors' methods: A comprehensive and systematic literature search was conducted on July 12, 2023. The search was done of commercial medical literature databases using a combination of key words.
Details
Project Status: Completed
Year Published: 2023
English language abstract: An English language summary is available
Publication Type: Mini HTA
Country: Canada
MeSH Terms
  • COVID-19
  • COVID-19 Vaccines
  • SARS-CoV-2
  • Encephalomyelitis
  • Fatigue Syndrome, Chronic
  • mRNA Vaccines
  • Coronavirus Infections
Keywords
  • Myalgic encephalomyelitis
  • chronic fatigue syndrome
  • mRNA
  • RNA messenger
  • vaccine
  • Pfizer
  • Moderna
Contact
Organisation Name: WorkSafeBC
Contact Address: 6591 Westminster Highway, Richmond, BC, V7C 1C6 Canada. Tel: 604-231-8417; Fax: 604-279-7698
Contact Name: ebpg@worksafebc.com
Contact Email: ebpg@worksafebc.com
Copyright: WorkSafe BC
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.